Company
Headquarters: Shanghai, China
Employees: 2,771
CN¥10.55 Billion
CNY as of July 1, 2025
US$1.47 Billion
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $162.07 B |
| Danaher | $144.92 B |
| Siemens Healthineers AG | $64.17 B |
| Lonza Group Ltd | $49.67 B |
| IDEXX Laboratories, Inc. | $43.99 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥7.90 B |
| EBITDA | CN¥589.9 M |
| Gross Profit TTM | CN¥1.89 B |
| Profit Margin | -0.46% |
| Operating Margin | -0.39% |
| Quarterly Revenue Growth | -19.80% |
Shanghai Runda Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603108 wb_incandescent